Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

Schizophrenia spectrum disorders significantly increase cardiovascular and metabolic disease risks, partly due to antipsychotic-induced weight gain and glucose dysregulation.

Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a broad patient population1Olanzapine LAI is designed to ...

Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.

People with schizophrenia often take strong antipsychotics that control symptoms but frequently cause rapid weight gain, high blood sugar, and a ...

Please provide your email address to receive an email when new articles are posted on . Cobenfy is the first antipsychotic medication to treat schizophrenia by targeting cholinergic receptors. The ...

A major scientific review reveals a deep knowledge gap in how cognition is affected when schizophrenia and personality disorders occur together.

If you or a loved one has schizophrenia, you may wonder how the condition will impact you as you age. Even with treatment, schizophrenia can affect your brain and body in different ways as you get ...

Few movies and TV shows accurately depict schizophrenia, and even fewer feature women with the condition—which undoubtedly plays a role in the misconception that schizophrenia only occurs in men. The ...

People living with schizophrenia continue to battle not just their symptoms, delayed diagnoses and access to quality ...